White label ELPA - ClinicalTrials.eu

Study on Denosumab for Improving Semen Quality in Men with Non-Obstructive Azoospermia

Not recruiting

2 1 1 1
Investigated Diseases:
- Infertility male
Investigated Drugs:
- Denosumab
- Letrozole
Study of Disitamab Vedotin and Pembrolizumab for Patients with Untreated Advanced Urothelial Cancer Expressing HER2

Not recruiting

3 1 1 1
Investigated Drugs:
+7
Study on Riliprubart for Preventing and Treating Antibody-Mediated Rejection in Adult Kidney Transplant Patients

Not recruiting

2 1 1
Investigated Diseases:
- Transplant rejection
Investigated Drugs:
- Riliprubart
Study on the Effectiveness and Safety of Pirtobrutinib vs. Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma

Not recruiting

3 1 1 1
Investigated Diseases:
- Mantle cell lymphoma
Investigated Drugs:
- Pirtobrutinib
- Ibrutinib
+5
Study on the Effectiveness and Safety of Budesonide and Formoterol Fumarate for Patients with Poorly Controlled Asthma

Not recruiting

3 1 1
Investigated Diseases:
- Asthma
Investigated Drugs:
Study on Acalabrutinib and Venetoclax for Newly Diagnosed Chronic Lymphocytic Leukemia Patients at High Risk of Infection and Early Treatment Needs

Not recruiting

2 1 1 1
Investigated Drugs:
- Acalabrutinib
- Venetoclax
Study of Gilteritinib and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia with FLT3 Mutation in Patients Not Eligible for Intensive Chemotherapy

Not recruiting

3 1 1 1
Investigated Diseases:
- Acute myeloid leukaemia
Investigated Drugs:
- Gilteritinib
- Azacitidine
Study on the Effectiveness and Safety of Ralinepag for Patients with Pulmonary Arterial Hypertension

Not recruiting

3 1
Investigated Diseases:
- Pulmonary hypertension
Investigated Drugs:
- Ralinepag
+9
Study on the Effectiveness and Safety of BIIB122 for Patients with Parkinson’s Disease

Not recruiting

2 1
Investigated Diseases:
- Parkinson’s disease
Investigated Drugs:
- N2-(3-(2-(2H-1,2,3-Triazol-2-Yl)Propan-2-Yl)-1-Cyclopropyl-1H-Pyrazol-5-Yl)-N4-Ethyl-5-(Trifluoromethyl)Pyrimidine-2,4-Diamine
+1
Study of Amivantamab and Lazertinib Combination vs. Osimertinib vs. Lazertinib for First-Line Treatment in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer

Not recruiting

3 1 1
Investigated Drugs:
+3

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies